Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FRUQUINTINIB vs GABAPENTIN ENACARBIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FRUQUINTINIB vs GABAPENTIN ENACARBIL: Safety Overview

Metric FRUQUINTINIB GABAPENTIN ENACARBIL
Total FAERS Reports 2,565 1,833
Deaths Reported 874 649
Death Rate 34.1% 35.4%
Hospitalizations 753 237
Average Patient Age 63.9 yrs 54.6 yrs
% Female Patients 44.4% 61.5%
FDA Approval Date Nov 8, 2023 Apr 6, 2011
Manufacturer Takeda Pharmaceuticals America, Inc. Azurity Pharmaceuticals, Inc. (former...
Route ORAL ORAL
Marketing Status Prescription Prescription